Get started
Author

Delphine Planas

Observed names: D. Planas, Delphine, Planas, Planas, D, Planas, Delphine, Planas2, Delphine
Institutions: Centre National de la Recherche Scientifique, Inserm, Institut Pasteur, Université Paris Cité, Université Sorbonne Paris Nord, Department of Virology, Institut de Recherche Vaccinale, Centre Hospitalier de l’Université de Montréal, Infection, Anti-microbiens, Modélisation, Evolution
Observed institutions: California Institute of Technology, Centre National de la Recherche Scientifique, Inserm, Institut Pasteur, Université Paris-Est Créteil, Université Paris Cité, Université Paris-Saclay, Université Sorbonne Paris Nord, Department of Virology, Institut de Recherche Vaccinale, Centre Hospitalier de l’Université de Montréal, Infection, Anti-microbiens, Modélisation, Evolution, Université de Montréal
ORCID: 0000-0002-2509-9954
Observed ORCID: 0000-0002-2509-9954
OpenAlex ID: A5044251474
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
2021 · Delphine Planas, David Veyer, et al. · Nature · 2,089
PDF
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
2021 · Delphine Planas, Nell Saunders, et al. · Nature · 1,477
PDF
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
2021 · Delphine Planas, Timothée Bruel, et al. · Nature Medicine · 686
PDF
Syncytia formation by SARS‐CoV‐2‐infected cells
2020 · Julian Buchrieser, Jeremy Dufloo, et al. · The EMBO Journal · 463
PDF
A comparative analysis of prophylactic antimicrobial use in long-term care facilities in Ireland, 2013 and 2016
2016 · Woudenberg, Tom, Pinaud, Laurie, et al. · Radboud Repository (Radboud University) · 341
PDF
Erratum To: Syncytia formation by SARS‐CoV‐2‐infected cells
2021 · Julian Buchrieser, Jérémy Dufloo, et al. · The EMBO Journal · 330
PDF
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
2020 · Ludivine Grzelak, Sarah Temmam, et al. · Science Translational Medicine · 308
PDF
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
2022 · Timothée Bruel, Jérôme Hadjadj, et al. · Nature Medicine · 276
PDF
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2024 · Delphine Planas, Isabelle Staropoli, et al. · Nature Communications · 263
PDF
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
2021 · Floriane Gallais, Pierre Gantner, et al. · EBioMedicine · 233
PDF
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
2023 · Delphine Planas, Timothée Bruel, et al. · Nature Communications · 199
PDF
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
2021 · Delphine Planas, Nell Saunders, et al. · Nature · 194
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
2021 · Maaran Michael Rajah, Mathieu Hubert, et al. · The EMBO Journal · 192
PDF
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
2021 · Stéphane Marot, Isabelle Malet, et al. · Nature Communications · 173
PDF
HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy
2016 · Annie Gosselin, Tomas Raul Wiche Salinas, et al. · AIDS · 142
HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms
2017 · Delphine Planas, Yuwei Zhang, et al. · JCI Insight · 92
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
2022 · Cyril Planchais, Ignacio Fernández, et al. · The Journal of Experimental Medicine · 74
PDF
LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy
2021 · Delphine Planas, Amélie Pagliuzza, et al. · EBioMedicine · 73
PDF
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
2023 · Mathieu Hubert, Florence Guivel-Benhassine, et al. · Cell Host & Microbe · 66
PDF
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
2021 · Stéphane Pelleau, Tom Woudenberg, et al. · The Journal of Infectious Diseases · 64
PDF
Identification of novel HIV-1 dependency factors in primary CCR4+CCR6+Th17 cells via a genome-wide transcriptional approach
2015 · Aurélie Cleret-Buhot, Yuwei Zhang, et al. · Retrovirology · 64
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
2022 · Timothée Bruel, Karl Stéfic, et al. · Cell Reports Medicine · 62
PDF
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
2022 · Ilies Benotmane, Timothée Bruel, et al. · Kidney International · 53
PDF
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
2024 · Delphine Planas, Isabelle Staropoli, et al. · Pathogens and Immunity · 52
PDF
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota
2020 · Stéphane Isnard, John Lin, et al. · Open Forum Infectious Diseases · 51
PDF
Works count: 107
Citation count: 9,054
H-index: 36
I10-index: 61
Year
Topic
Type